Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Intracranial hemorrhage during dabigatran treatment.

Komori M, Yasaka M, Kokuba K, Matsuoka H, Fujimoto S, Yoshida M, Kameda K, Shono T, Nagata S, Ago T, Kitazono T, Okada Y.

Circ J. 2014;78(6):1335-41. Epub 2014 Mar 24.

2.

Bleeding rates in Veterans Affairs patients with atrial fibrillation who switch from warfarin to dabigatran.

Vaughan Sarrazin MS, Jones M, Mazur A, Chrischilles E, Cram P.

Am J Med. 2014 Dec;127(12):1179-85. doi: 10.1016/j.amjmed.2014.07.024. Epub 2014 Aug 12.

PMID:
25107386
3.

Traumatic intracranial hemorrhage in patients taking dabigatran: report of 3 cases and review of the literature.

Wassef SN, Abel TJ, Grossbach A, Viljoen SV, Jackson AW, Howard MA 3rd, Greenlee JD.

Neurosurgery. 2013 Aug;73(2):E368-73; discussion E373-4. doi: 10.1227/01.neu.0000430763.95349.5f. Review.

PMID:
23670031
4.

Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial.

Hart RG, Diener HC, Yang S, Connolly SJ, Wallentin L, Reilly PA, Ezekowitz MD, Yusuf S.

Stroke. 2012 Jun;43(6):1511-7. doi: 10.1161/STROKEAHA.112.650614. Epub 2012 Apr 5.

5.

Management and outcomes of major bleeding during treatment with dabigatran or warfarin.

Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, Brueckmann M, Fraessdorf M, Yusuf S, Schulman S.

Circulation. 2013 Nov 19;128(21):2325-32. doi: 10.1161/CIRCULATIONAHA.113.002332. Epub 2013 Sep 30.

6.

Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage.

Aron JL, Gosselin R, Moll S, Arkin CF, Mantha S.

J Thromb Thrombolysis. 2014;37(2):76-9. doi: 10.1007/s11239-013-0913-0. No abstract available.

PMID:
23519385
7.

Clinical experience of life-threatening dabigatran-related bleeding at a large, tertiary care, academic medical center: a case series.

Ross B, Miller MA, Ditch K, Tran M.

J Med Toxicol. 2014 Jun;10(2):223-8. doi: 10.1007/s13181-013-0364-1.

8.

Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice.

Kawabata M, Yokoyama Y, Sasano T, Hachiya H, Tanaka Y, Yagishita A, Sugiyama K, Nakamura T, Suzuki M, Isobe M, Hirao K.

J Cardiol. 2013 Aug;62(2):121-6. doi: 10.1016/j.jjcc.2013.03.010. Epub 2013 May 14.

9.

Risk of bleeding with dabigatran in atrial fibrillation.

Hernandez I, Baik SH, Piñera A, Zhang Y.

JAMA Intern Med. 2015 Jan;175(1):18-24. doi: 10.1001/jamainternmed.2014.5398.

PMID:
25365537
10.

Intracranial hemorrhage mortality in atrial fibrillation patients treated with dabigatran or warfarin.

Alonso A, Bengtson LG, MacLehose RF, Lutsey PL, Chen LY, Lakshminarayan K.

Stroke. 2014 Aug;45(8):2286-91. doi: 10.1161/STROKEAHA.114.006016. Epub 2014 Jul 3.

11.

Comparison of dabigatran and uninterrupted warfarin in patients with atrial fibrillation undergoing cardiac rhythm device implantations. Case-control study.

Kosiuk J, Koutalas E, Doering M, Nedios S, Sommer P, Rolf S, Darma A, Breithardt OA, Dinov B, Hindricks G, Richter S, Bollmann A.

Circ J. 2014;78(10):2402-7. Epub 2014 Aug 22.

12.

Gastrointestinal bleeding under dabigatran.

Stöllberger C, Lindner K, Finsterer J.

J Postgrad Med. 2014 Apr-Jun;60(2):192-3. doi: 10.4103/0022-3859.132343.

13.

Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.

Eikelboom JW, Wallentin L, Connolly SJ, Ezekowitz M, Healey JS, Oldgren J, Yang S, Alings M, Kaatz S, Hohnloser SH, Diener HC, Franzosi MG, Huber K, Reilly P, Varrone J, Yusuf S.

Circulation. 2011 May 31;123(21):2363-72. doi: 10.1161/CIRCULATIONAHA.110.004747. Epub 2011 May 16.

14.

Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation.

Larsen TB, Gorst-Rasmussen A, Rasmussen LH, Skjøth F, Rosenzweig M, Lip GY.

Am J Med. 2014 Jul;127(7):650-656.e5. doi: 10.1016/j.amjmed.2014.01.031. Epub 2014 Feb 13.

PMID:
24530792
15.

New era of oral anticoagulation for Japanese non-valvular atrial fibrillation patients.

Hirano T.

Circ J. 2014;78(6):1317-9. Epub 2014 May 7. No abstract available.

16.

Application of the RELY study to lifetime risks of atrial fibrillation: implications for spontaneous intracranial hemorrhage.

Parry PV, Engh JA.

Neurosurgery. 2012 Feb;70(2):N10-1. doi: 10.1227/NEU.0b013e3181ae7dd2. No abstract available.

PMID:
22251978
17.

The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.

Connolly SJ, Wallentin L, Ezekowitz MD, Eikelboom J, Oldgren J, Reilly PA, Brueckmann M, Pogue J, Alings M, Amerena JV, Avezum A, Baumgartner I, Budaj AJ, Chen JH, Dans AL, Darius H, Di Pasquale G, Ferreira J, Flaker GC, Flather MD, Franzosi MG, Golitsyn SP, Halon DA, Heidbuchel H, Hohnloser SH, Huber K, Jansky P, Kamensky G, Keltai M, Kim SS, Lau CP, Le Heuzey JY, Lewis BS, Liu L, Nanas J, Omar R, Pais P, Pedersen KE, Piegas LS, Raev D, Smith PJ, Talajic M, Tan RS, Tanomsup S, Toivonen L, Vinereanu D, Xavier D, Zhu J, Wang SQ, Duffy CO, Themeles E, Yusuf S.

Circulation. 2013 Jul 16;128(3):237-43. doi: 10.1161/CIRCULATIONAHA.112.001139. Epub 2013 Jun 14.

18.

CHA2DS2-VASc and HAS-BLED scores and activated partial thromboplastin time for prediction of high plasma concentration of dabigatran at trough.

Owada S, Tomita H, Kinjo T, Ishida Y, Itoh T, Sasaki K, Horiuchi D, Kimura M, Sasaki S, Okumura K.

Thromb Res. 2015 Jan;135(1):62-7. doi: 10.1016/j.thromres.2014.10.025. Epub 2014 Nov 4.

PMID:
25466835
19.

Dabigatran-induced acute hepatitis.

Rochwerg B, Xenodemetropoulos T, Crowther M, Spyropoulos A.

Clin Appl Thromb Hemost. 2012 Sep;18(5):549-50. doi: 10.1177/1076029611435840. No abstract available.

PMID:
22962308
20.

Dabigatran for stroke prevention in atrial fibrillation.

Hohnloser SH, Diener HC.

Hamostaseologie. 2012;32(3):216-20. doi: 10.5482/ha-1196. Epub 2012 Jun 28.

PMID:
22739760

Supplemental Content

Support Center